Protocol for generating airway organoids from 2D air liquid interface-differentiated nasal epithelia for use in a functional CFTR assay
Rodenburg, Lisa W; van der Windt, Isabelle S; Dreyer, Henriette H M; Smits, Shannon M A; den Hertog-Oosterhoff, Loes A; Aarts, Ellen M; Beekman, Jeffrey M; Amatngalim, Gimano D
(2023) STAR protocols, volume 4, issue 3, pp. 1 - 28
(Article)
Abstract
We present a protocol to generate organoids from air-liquid-interface (ALI)-differentiated nasal epithelia. We detail their application as cystic fibrosis (CF) disease model in the cystic fibrosis transmembrane conductance regulator (CFTR)-dependent forskolin-induced swelling (FIS) assay. We describe steps for isolation, expansion and cryostorage of nasal brushing-derived basal progenitor cells, and their
... read more
differentiation in ALI cultures. Furthermore, we detail the conversion of differentiated epithelial fragments into organoids of healthy controls and CF subjects for validating CFTR function and modulator responses. For complete details on the use and execution of this protocol, please refer to Amatngalim et al.1
show less
Download/Full Text
Keywords: Cell culture, Organoids, General Biochemistry,Genetics and Molecular Biology, General Immunology and Microbiology, General Neuroscience, Journal Article
ISSN: 2666-1667
Publisher: Cell Press
Note: Funding Information: This work was supported by grants of the Dutch Cystic Fibrosis Foundation (NCFS, HIT-CF grant), SRC 013 from CF Trust-UK and Health Holland. Conceptualization, J.M.B. G.D.A.; methodology, G.D.A.; validation, formal analysis, investigation, and data curation, L.W.R. I.S.W. H.H.M.D. S.M.A.S. L.A.H.O. E.M.A. G.D.A.; resources, J.M.B.; writing – original draft, L.W.R. I.S.W.; writing – review & editing, H.H.M.D. S.M.A.S. L.A.H.O. E.M.A. J.M.B. G.D.A.; visualization, L.W.R. I.S.W.; supervision, J.M.B. G.D.A.; funding acquisition, J.M.B. G.D.A. J.M.B. has a patent granted (10006904) related to CFTR function measurements in intestinal organoids and received personal fees from HUB/Royal Dutch academy of sciences, during the conduct of the study. He received nonfinancial support from Vertex Pharmaceuticals and personal fees and nonfinancial support from Proteostasis Therapeutics, outside the submitted work. Funding Information: This work was supported by grants of the Dutch Cystic Fibrosis Foundation (NCFS, HIT-CF grant), SRC 013 from CF Trust-UK and Health Holland . Publisher Copyright: © 2023 The Authors
(Peer reviewed)
